Therapeutic Potential of EP3 Receptor Antagonists for Treatment of Noninsulin Dependent Diabetes Mellitus across Multiple Preclinical ModelsMatthew M. Rankin, Lisa Norquay, Ivona Bakaj et al.|Diabetes|2018Cited by 2